null

Human EGFR Phosphorylation Array (16 targets) (SARB0062)

SKU:
SARB0062
Product Type:
Phosphorylation Array
Analytes:
EGFR (P-Tyr845)
EGFR (P-Tyr992)
EGFR (P-Tyr1045)
EGFR (P-Tyr1068)
EGFR (P-Tyr1086)
EGFR (P-Tyr1148)
EGFR (P-Tyr1173)
EGFR (P-Ser1046/1047)
ErbB2 (P-Tyr877)
ErbB2 (P-Tyr1112)
ErbB2 (P-Tyr 1221/1222)
ErbB2 (P-Tyr1248)
ErbB2 (P-Thr686)
ErbB2 (P-Ser1113)
ErbB3 (P-Tyr1289)
ErbB4 (P-Tyr1284)
Reactivity:
Human
Applications:
Multiplex Array
$623 - $1,199
Frequently bought together:

Description

system_update_altDatasheet

Human EGFR Phosphorylation Array (16 targets) (SARB0062)

The Human EGFR Phosphorylation Array (SARB0062) is a powerful tool for studying the phosphorylation status of 16 different targets related to the epidermal growth factor receptor (EGFR) pathway. This array allows for the simultaneous detection and analysis of multiple phosphorylation events, providing valuable insights into signaling cascades and cellular responses.Each target on the array is carefully selected to provide comprehensive coverage of key components involved in EGFR signaling, including downstream effectors and regulators. The array is highly sensitive and specific, enabling the detection of subtle changes in phosphorylation levels that may be indicative of pathway activation or inhibition.Researchers can use the Human EGFR Phosphorylation Array to profile the phosphorylation status of multiple targets in a single experiment, saving time and resources compared to traditional methods.

This array is suitable for use with human samples, making it an invaluable tool for studying EGFR signaling in various physiological and pathological conditions.Overall, the Human EGFR Phosphorylation Array (SARB0062) is a versatile and reliable platform for investigating the complex network of signaling events associated with EGFR activation. Whether studying cancer, inflammation, or other disease processes, this array provides a comprehensive view of EGFR pathway activity, opening up new possibilities for research and drug development.